Overview
Wolverine Blend is the famous dual-action recovery formula combining the two most researched healing peptides: BPC-157 and TB-500.
What problem it targets: It targets acute and chronic tendonitis, torn ligaments, muscle strains, joint wear, and post-surgical recovery, aiming to rebuild tissue rather than masking pain.
What It Does
• Dual local and systemic tissue repair: BPC-157 drives rapid localized blood vessel formation (angiogenesis), while TB-500 mobilizes actin to move healing cells across the body.
• Rebuilds organized structural collagen: Coordinates cellular repair so that new collagen fibers lay down in strong, parallel, flexible patterns rather than brittle scar tissue.
• Quenches deep inflammation without slowing repair: Unlike NSAID painkillers (Advil, ibuprofen) which mask symptoms while slowing tissue healing, this blend accelerates genuine cellular repair.
• Realistic expectations: Injected subcutaneously daily or multiple times per week. Most users experience marked reductions in pain and joint stiffness within 10 to 14 days, with structural healing over 4 to 8 weeks.
Reconstitution
| Vial size | BAC water or Solvent | Concentration |
|---|---|---|
| 10 mg | + 1 mL | 10 mg/mL |
| 20 mg | + 2 mL | 10 mg/mL |
| 30 mg | + 3 mL | 10 mg/mL |
Protocol
| Phase | Frequency | Dose | Notes |
|---|---|---|---|
| Weeks 1–2 | Daily | 500 | Loading: assess tolerance. Daily because BPC-157’s serum half-life is short (~30 min); TB-500 rides along in |
| mcg | the pre-mixed vial (weekly as a standalone). | ||
| Weeks 3–4 | Daily | 750 | Step up only if Weeks 1–2 well tolerated. Half-unit step is optional – many users go directly to 1 mg. |
| (Aggressive) | mcg | ||
| Weeks 5–10 | Daily AM | 1 mg | Working dose. Once daily preferred; optional AM/PM split (5u + 5u) if you find injection volume uncomfortable. |
| Aggressive | Twice daily (AM + | 1 mg | For acute injury, post-surgical recovery, or a stalled response. 1 mg blend twice daily = 1 mg of each |
| PM split) | ×2 | component daily. 4–6 weeks, then taper to the daily working dose. | |
| Off | 2–4 weeks | – | Standard washout. Re-cycle if continued tissue work needed. Cycle: 8–10 weeks on / 2–4 weeks off (daily microdose). Aggressive (twice daily, acute injury): 4–6 weeks split-dose / 4 weeks off, then back to daily working dose. Timing: Daily, anytime; Wolverine Blend; food doesn’t affect By sex: Unisex (BPC-157 + TB-500 recovery), same protocol for men and women, no cycle effect. Avoid in pregnancy. |
Handling & Stacking
- Faster recovery than either alone.
- Pain reduction within days, structural repair over 4–12 weeks.
- Systemic anti-inflammatory effect complements localised healing.
- Supply math 10mg → 6 vials | 20mg → 3 vials | 30mg → 2 vials (10-wk @ 1 mg × 7/wk)
- NSAIDs during a repair cycle (ibuprofen/Advil/Aleve slow healing on their own; use Tylenol for pain).
- Active malignancy.
- High-dose vitamin C same session.
- GLOW / KLOW Blend (already contains BPC + TB – would double-dose)
Safety & Patient Education
- Active or suspected malignancy.
- TB-500 is angiogenic systemically, BPC-157 drives angiogenesis locally via VEGF.
- Theoretical, but neither can tell healthy tissue from a tumour you don’t know about.
- Screen age-appropriately before a long run; stop for any new lump.
- Active bleeding or recent hemorrhagic stroke (TB-500 vascular) Pregnancy, lactation
- Two-peptide stack, any single-component contraindication applies.
- Active cancer is an absolute stop Both are research peptides without published human RCTs.
- All use is off-label; quality varies Local injection near target tissue for orthopedic use; SubQ near abdomen for systemic.
- Rotate sites Cycle: 4–6 wks on / 2–4 wks off.
- Continuous dosing isn’t supported and may blunt response
